294 related articles for article (PubMed ID: 15586316)
41. Metabolic risk during antipsychotic treatment.
Newcomer JW
Clin Ther; 2004 Dec; 26(12):1936-46. PubMed ID: 15823759
[TBL] [Abstract][Full Text] [Related]
42. [The physiopathology of weight regulation during treatment with psychotropic drugs].
Kraus T; Zimmermann U; Schuld A; Haack M; Hinze-Selch D; Pollmächer T
Fortschr Neurol Psychiatr; 2001 Mar; 69(3):116-37. PubMed ID: 11305122
[TBL] [Abstract][Full Text] [Related]
43. Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia.
Casey DE; Haupt DW; Newcomer JW; Henderson DC; Sernyak MJ; Davidson M; Lindenmayer JP; Manoukian SV; Banerji MA; Lebovitz HE; Hennekens CH
J Clin Psychiatry; 2004; 65 Suppl 7():4-18; quiz 19-20. PubMed ID: 15151456
[No Abstract] [Full Text] [Related]
44. Acute weight gain induced by amisulpride monotherapy in a first-episode schizophrenic patient.
Papadimitriou GN; Theleritis CG; Dikeos DG; Psarros CJ; Soldatos CR
Int Clin Psychopharmacol; 2006 May; 21(3):181-4. PubMed ID: 16528141
[TBL] [Abstract][Full Text] [Related]
45. Memantine-associated reversal of clozapine-induced weight gain.
Schaefer M; Leopold K; Hinzpeter A; Heinz A; Krebs M
Pharmacopsychiatry; 2007 Jul; 40(4):149-51. PubMed ID: 17694477
[TBL] [Abstract][Full Text] [Related]
46. Impact of antipsychotic treatments on the motivation to eat: preliminary results in 153 schizophrenic patients.
Sentissi O; Viala A; Bourdel MC; Kaminski F; Bellisle F; Olié JP; Poirier MF
Int Clin Psychopharmacol; 2009 Sep; 24(5):257-64. PubMed ID: 19606055
[TBL] [Abstract][Full Text] [Related]
47. [Metabolic risk during antipsychotic treatment in patients with schizophrenia].
Rzewuska M
Psychiatr Pol; 2007; 41(4):457-72. PubMed ID: 18046977
[TBL] [Abstract][Full Text] [Related]
48. Weight gain with atypical antipsychotics: evidence and insights.
Henderson DC
J Clin Psychiatry; 2007; 68 Suppl 12():18-26. PubMed ID: 17956152
[TBL] [Abstract][Full Text] [Related]
49. [On the clinical relevance of clozapine-triggered release of cytokines and soluble cytokine-receptors].
Pollmächer T; Schuld A; Kraus T; Haack M; Hinze-Selch D
Fortschr Neurol Psychiatr; 2001 Sep; 69 Suppl 2():S65-74. PubMed ID: 11533853
[TBL] [Abstract][Full Text] [Related]
50. Atypical antipsychotics and weight gain.
Postgrad Med; 2003 Dec; 114(6 Suppl Managing Metabolic):46-58. PubMed ID: 19667655
[TBL] [Abstract][Full Text] [Related]
51. Psychiatric medication-induced obesity: a review.
Schwartz TL; Nihalani N; Jindal S; Virk S; Jones N
Obes Rev; 2004 May; 5(2):115-21. PubMed ID: 15086865
[TBL] [Abstract][Full Text] [Related]
52. [Schizophrenia, obesity and pharmacotherapy-associated weight gain].
Carpiniello B; Corda E; Maccioni R; Pinna F
Clin Ter; 2008; 159(5):299-306. PubMed ID: 18998030
[TBL] [Abstract][Full Text] [Related]
53. A preliminary investigation of alpha-lipoic acid treatment of antipsychotic drug-induced weight gain in patients with schizophrenia.
Kim E; Park DW; Choi SH; Kim JJ; Cho HS
J Clin Psychopharmacol; 2008 Apr; 28(2):138-46. PubMed ID: 18344723
[TBL] [Abstract][Full Text] [Related]
54. Management of weight gain associated with antipsychotics.
Birt J
Ann Clin Psychiatry; 2003 Mar; 15(1):49-58. PubMed ID: 12839432
[TBL] [Abstract][Full Text] [Related]
55. DRD4 48 bp VNTR but not 5-HT 2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain.
Popp J; Leucht S; Heres S; Steimer W
Pharmacogenomics J; 2009 Feb; 9(1):71-7. PubMed ID: 18332898
[TBL] [Abstract][Full Text] [Related]
56. Introduction. Weight gain with psychotropics: size does matter.
Masand PS
J Clin Psychiatry; 1999; 60 Suppl 21():3-4. PubMed ID: 10548134
[No Abstract] [Full Text] [Related]
57. HTR2C haplotypes and antipsychotics-induced weight gain: X-linked multimarker analysis.
De Luca V; Müller DJ; Hwang R; Lieberman JA; Volavka J; Meltzer HY; Kennedy JL
Hum Psychopharmacol; 2007 Oct; 22(7):463-7. PubMed ID: 17702092
[TBL] [Abstract][Full Text] [Related]
58. Abnormalities of glucose metabolism associated with atypical antipsychotic drugs.
Newcomer JW
J Clin Psychiatry; 2004; 65 Suppl 18():36-46. PubMed ID: 15600383
[TBL] [Abstract][Full Text] [Related]
59. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
Turner MS; Stewart DW
J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
[TBL] [Abstract][Full Text] [Related]
60. Pharmacological management of atypical antipsychotic-induced weight gain.
Baptista T; ElFakih Y; Uzcátegui E; Sandia I; Tálamo E; Araujo de Baptista E; Beaulieu S
CNS Drugs; 2008; 22(6):477-95. PubMed ID: 18484791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
